Inhalers that use CFCs will be phased out

Seven Inhalers That Use CFCs Being Phased Out

On April 13, 2010, the Food and Drug Administration (FDA) announced that seven metered dose inhalers that contain chlorofluorocarbons (CFCs) are being phased out in the United States.

• Tilade Inhaler (nedocromil), made by King Pharmaceuticals, last date for sale: June 14, 2010
• Alupent Inhalation Aerosol (metaproterenol), made by Boehringer Ingelheim Pharmaceuticals, last date for sale: June 14, 2010
• Azmacort Inhalation Aerosol (triamcinolone), made by Abbott Laboratories, last date for sale: Dec. 31, 2010
• Intal Inhaler (cromolyn), made by King Pharmaceuticals, last date for sale: Dec. 31, 2010
• Aerobid Inhaler System (flunisolide), made by Forest Laboratories, last date for sale: June 30, 2011
• Combivent Inhalation Aerosol (albuterol and ipratropium in combination), made by Boehringer Ingelheim Pharmaceuticals, last date for sale: Dec. 31, 2013
• Maxair Autohaler (pirbuterol), made by Graceway Pharmaceuticals, last date for sale: Dec. 31, 2013

These medications are used for the treatment of asthma or COPD. Speaking of COPD, the New England Journal of Medicine (NEJM) just released an article titled, "Outpatient Management of Severe COPD." You won't want to miss that one.

You can learn more inhalers being phased out here.